FABP5P3

Across TCGA pan-cancer cohorts, FABP5P3 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated FABP5P3 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher FABP5P3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FABP5P3 expression acts as an unfavorable survival marker, although some lineages such as UCEC and LUSC show a favorable association.

STAD, DLBC, and UCEC are the cancer types where FABP5P3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.093	0.690	<.001	54	view →
DLBC	DFS	Median	II,III,IV	0.022	0.837	<.001	12	view →
UCEC	DFS	Median	All	1.000	0.629	.025	12	view →
LUSC	DFS	Median	All	1.000	0.372	.046	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

FABP5P3–STAD (OS)

Open the STAD breakdown →